Former pharmaceutical executive Martin Shkreli lost his bid on Friday to vacate one of his three felony securities fraud convictions while his legal team presented arguments to push back against the government’s efforts to seize more than $7.3 million of Shkreli’s assets.
Shkreli was convicted in August after a six-week trial on two counts of securities fraud and a related conspiracy charge running a scheme in which he defrauded investors into two hedge funds he created to launch a pharmaceutical company, eventually paying back the hedge fund investors from the proceeds.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Not a Bloomberg Law Subscriber?
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]